Empery Asset Management »

Benitec Biopharma shares owned by Empery Asset Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $747k 55k 13.47

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Immuneering Corp Class A Com (IMRX)
Empery Digital Com New (EMPD)
Imperial Pete Com New (IMPP)
Precision BioSciences Com New (DTIL)
Aduro Clean Technologies Com New (ADUR)
Tenaya Therapeutics (TNYA)
Critical Metals Corp Pubco Ord Shs (CRML)
Eos Energy Enterprises Com Cl A (EOSE)
Surrozen Com New (SRZN)
Talphera Com New (TLPH)
Kazia Therapeutics Sponsored Ads (KZIA)
Profound Med Corp Com New (PROF)
Robin Energy Ord Shs New (RBNE)
Super League Enterprise Com New (SLE)

View all positions for Empery Asset Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Geode Capital Management
AWM Investment Company
Schonfeld Strategic Advisors
State Street Corporation

View all funds holding Benitec Biopharma